Literature DB >> 20696985

Role of phosphoinositide 3-kinase {alpha}, protein kinase C, and L-type Ca2+ channels in mediating the complex actions of angiotensin II on mouse cardiac contractility.

Wenbin Liang1, Gavin Y Oudit, Mikin M Patel, Ajay M Shah, James R Woodgett, Robert G Tsushima, Michael E Ward, Peter H Backx.   

Abstract

Although angiotensin II (Ang II) plays an important role in heart disease associated with pump dysfunction, its direct effects on cardiac pump function remain controversial. We found that after Ang II infusion, the developed pressure and +dP/dt(max) in isolated Langendorff-perfused mouse hearts showed a complex temporal response, with a rapid transient decrease followed by an increase above baseline. Similar time-dependent changes in cell shortening and L-type Ca(2+) currents were observed in isolated ventricular myocytes. Previous studies have established that Ang II signaling involves phosphoinositide 3-kinases (PI3K). Dominant-negative inhibition of PI3Kalpha in the myocardium selectively eliminated the rapid negative inotropic action of Ang II (inhibited by approximately 90%), whereas the loss of PI3Kgamma had no effect on the response to Ang II. Consistent with a link between PI3Kalpha and protein kinase C (PKC), PKC inhibition (with GF 109203X) reduced the negative inotropic effects of Ang II by approximately 50%. Although PI3Kalpha and PKC activities are associated with glycogen synthase kinase-3beta and NADPH oxidase, genetic ablation of either glycogen synthase kinase-3beta or p47(phox) (an essential subunit of NOX2-NADPH oxidase) had no effect on the inotropic actions of Ang II. Our results establish that Ang II has complex temporal effects on contractility and L-type Ca(2+) channels in normal mouse myocardium, with the negative inotropic effects requiring PI3Kalpha and PKC activities.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20696985      PMCID: PMC4485474          DOI: 10.1161/HYPERTENSIONAHA.109.149344

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  56 in total

1.  Phosphoinositide 3-kinase gamma mediates angiotensin II-induced stimulation of L-type calcium channels in vascular myocytes.

Authors:  J F Quignard; J Mironneau; V Carricaburu; B Fournier; A Babich; B Nurnberg; C Mironneau; N Macrez
Journal:  J Biol Chem       Date:  2001-07-06       Impact factor: 5.157

2.  The phosphoinositide 3-kinase inhibitor LY294002 enhances cardiac myocyte contractility via a direct inhibition of Ik,slow currents.

Authors:  Hui Sun; Gavin Y Oudit; Rafael J Ramirez; Danny Costantini; Peter H Backx
Journal:  Cardiovasc Res       Date:  2004-06-01       Impact factor: 10.787

3.  Phosphorylation of glycogen synthase kinase-3beta during preconditioning through a phosphatidylinositol-3-kinase--dependent pathway is cardioprotective.

Authors:  Haiyan Tong; Kenichi Imahashi; Charles Steenbergen; Elizabeth Murphy
Journal:  Circ Res       Date:  2002-03-08       Impact factor: 17.367

4.  Convergence of multiple signaling cascades at glycogen synthase kinase 3: Edg receptor-mediated phosphorylation and inactivation by lysophosphatidic acid through a protein kinase C-dependent intracellular pathway.

Authors:  Xianjun Fang; Shuangxing Yu; Janos L Tanyi; Yiling Lu; James R Woodgett; Gordon B Mills
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

Review 5.  Phosphoinositide 3-kinase gamma regulates cardiac contractility by locally controlling cyclic adenosine monophosphate levels.

Authors:  Benoit-Gilles Kerfant; Robert A Rose; Hui Sun; Peter H Backx
Journal:  Trends Cardiovasc Med       Date:  2006-10       Impact factor: 6.677

6.  Effects of K(ATP) channel openers, P-1075, pinacidil, and diazoxide, on energetics and contractile function in isolated rat hearts.

Authors:  Olga Jilkina; Bozena Kuzio; Gary J Grover; Valery V Kupriyanov
Journal:  J Mol Cell Cardiol       Date:  2002-04       Impact factor: 5.000

7.  Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype.

Authors:  J Sadoshima; S Izumo
Journal:  Circ Res       Date:  1993-09       Impact factor: 17.367

8.  Glycogen synthase kinase-3beta regulates growth, calcium homeostasis, and diastolic function in the heart.

Authors:  Ashour Michael; Syed Haq; Xin Chen; Eileen Hsich; Lei Cui; Brian Walters; Zhili Shao; Kausik Bhattacharya; Heiko Kilter; Gordon Huggins; Michele Andreucci; Muthu Periasamy; Robert N Solomon; Ronglih Liao; Richard Patten; Jeffery D Molkentin; Thomas Force
Journal:  J Biol Chem       Date:  2004-03-11       Impact factor: 5.157

9.  Inhibition of receptor-localized PI3K preserves cardiac beta-adrenergic receptor function and ameliorates pressure overload heart failure.

Authors:  Jeffrey J Nienaber; Hideo Tachibana; Sathyamangla V Naga Prasad; Giovanni Esposito; Dianqing Wu; Lan Mao; Howard A Rockman
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

10.  Protein kinase C{alpha}, but not PKC{beta} or PKC{gamma}, regulates contractility and heart failure susceptibility: implications for ruboxistaurin as a novel therapeutic approach.

Authors:  Qinghang Liu; Xiongwen Chen; Scott M Macdonnell; Evangelia G Kranias; John N Lorenz; Michael Leitges; Steven R Houser; Jeffery D Molkentin
Journal:  Circ Res       Date:  2009-06-25       Impact factor: 17.367

View more
  15 in total

Review 1.  Specific PI3K isoform modulation in heart failure: lessons from transgenic mice.

Authors:  Alessandra Ghigo; Fulvio Morello; Alessia Perino; Federico Damilano; Emilio Hirsch
Journal:  Curr Heart Fail Rep       Date:  2011-09

2.  Different roles of membrane potentials in electrotaxis and chemotaxis of dictyostelium cells.

Authors:  Run-Chi Gao; Xiao-Dong Zhang; Yao-Hui Sun; Yoichiro Kamimura; Alex Mogilner; Peter N Devreotes; Min Zhao
Journal:  Eukaryot Cell       Date:  2011-07-08

Review 3.  G protein-dependent and G protein-independent signaling pathways and their impact on cardiac function.

Authors:  Douglas G Tilley
Journal:  Circ Res       Date:  2011-07-08       Impact factor: 17.367

4.  Angiotensin II activates CaV 1.2 Ca2+ channels through β-arrestin2 and casein kinase 2 in mouse immature cardiomyocytes.

Authors:  Toshihide Kashihara; Tsutomu Nakada; Katsuhiko Kojima; Toshikazu Takeshita; Mitsuhiko Yamada
Journal:  J Physiol       Date:  2017-04-20       Impact factor: 5.182

5.  Association of Regulatory Genetic Variants for Protein Kinase Cα with Mortality and Drug Efficacy in Patients with Heart Failure.

Authors:  Jasmine A Luzum; Christopher Ting; Edward L Peterson; Hongsheng Gui; Tyler Shugg; L Keoki Williams; Liang Li; Wolfgang Sadee; Danxin Wang; David E Lanfear
Journal:  Cardiovasc Drugs Ther       Date:  2019-12       Impact factor: 3.727

6.  Hydrogen peroxide differentially modulates cardiac myocyte nitric oxide synthesis.

Authors:  Juliano L Sartoretto; Hermann Kalwa; Michael D Pluth; Stephen J Lippard; Thomas Michel
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-06       Impact factor: 11.205

7.  Importance of cell-cell contact in the therapeutic benefits of cardiosphere-derived cells.

Authors:  Yucai Xie; Ahmed Ibrahim; Ke Cheng; Zhijun Wu; Wenbin Liang; Konstantinos Malliaras; Baiming Sun; Weixin Liu; Deliang Shen; Hee Cheol Cho; Taosheng Li; Lin Lu; Guoping Lu; Eduardo Marbán
Journal:  Stem Cells       Date:  2014-09       Impact factor: 6.277

8.  Mural propagation of descending vasa recta responses to mechanical stimulation.

Authors:  Zhong Zhang; Kristie Payne; Chunhua Cao; Thomas L Pallone
Journal:  Am J Physiol Renal Physiol       Date:  2013-05-22

9.  Critical role of angiotensin II type 2 receptors in the control of mitochondrial and cardiac function in angiotensin II-preconditioned rat hearts.

Authors:  Rebeca E Nuñez; Sabzali Javadov; Nelson Escobales
Journal:  Pflugers Arch       Date:  2018-05-10       Impact factor: 3.657

Review 10.  Role of PI3K/Akt signaling pathway in cardiac fibrosis.

Authors:  Wuming Qin; Linghui Cao; Isaac Yaw Massey
Journal:  Mol Cell Biochem       Date:  2021-07-10       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.